Migraine clinical trials in Utah
8 studies for Migraine are looking for participants at sites in Utah.
Cities in Utah
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Advanced Research Institute Ogden, Ogden
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Nov 13, 2026 · NCT06972056A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Wasatch Clinical Research, LLC, Salt Lake City
- Highland Clinical Research, Salt Lake City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Pantheon Clinical Research, Bountiful
- J. Lewis Research, Inc. / Foothill Family Clinic Draper, Draper
- Advanced Research Institute, Ogden
- and 3 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 2, 2026 · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Pantheon Clinical Research /ID# 270259, Bountiful
- Alpine Research Organization - Clinton /ID# 276527, Clinton
- Highland Clinical Research /ID# 270281, Salt Lake City
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Oct 9, 2026 · NCT06810505Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Highland Clinical Research, Salt Lake City
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 9, 2026 · NCT07646613Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pantheon Clinical Research /ID# 250703, Bountiful
- Highland Clinical Research /ID# 239362, Salt Lake City
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.